Advanced search
Publication Cover
Future Oncology Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,831
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion

Wu Di1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142ChinaORCID Iconhttps://orcid.org/0000-0002-6993-8350
ORCID Icon,
Cong Yue2 Department of Ultrasound,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142,China
,
Zhang Ziran1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Zhang Jie1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Nie Jun1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Dai Ling1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Hu Weiheng1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Chen Xiaoling1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Ma Xiangjuan1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Tian Guangming1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Han Jindi1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Han Sen1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Wang Yang1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
,
Long Jieran1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142China
&
Fang Jian1 Department of Thoracic Oncology II,Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing),Peking University Cancer Hospital & Institute,Beijing,100142ChinaCorrespondence[email protected]
 show all
Pages 669-677 | Received 19 Aug 2021, Accepted 21 Oct 2021, Published online: 26 Jan 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.